| Revenue growth | 6.6% YoY for FY26 Consolidated. |
|---|---|
| Margins | EBITDA margins improved to 13.8% in FY26. |
| Order book | High-value orders deferred to subsequent quarters. |
| Demand visibility | Strong institutional relationships with pharma and academia. |
| Management confidence | High, targeting medium-term CAGR of 12-14%. |
Growth
FY26 Consolidated Revenue reached ₹467.3cr (6.6% growth); PAT grew 29.4% to ₹34.6cr.
Outlook
Medium-term Revenue CAGR target of 12-14% with focused margin improvement via high-value segments.
Risks
Impacted by one-time Ambad plant closure costs and sales reversal in Process Systems.
Earnings Call filed with NSE, NSE: BOROSCI. Summary written with AI assistance from the document.
Borosil Scientific Ltd: key numbers
- Share price
- ₹115.55
- Market cap
- ₹1,028 Cr
- Revenue (annual)
- ₹467.3 Cr
- Net profit (annual)
- ₹34.61 Cr
- P/E (TTM)
- 23.8×Sector 41.4×
- Promoter holding
- 68.27%+0.19% QoQ
- FII holding
- 0.23%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Borosil Scientific Ltd
All →Borosil Scientific Annual General Meeting
Borosil Scientific Limited held its 35th Annual General Meeting on September 25, 2026, via video conferencing to transact business stated in the notice.
Borosil Scientific Management Change
Mr. Kailash Motwani, Head of Operations at material subsidiary Pune & Goel Scientific Glass Works Limited, has resigned from his position as Senior Management Personnel.
Borosil Scientific Capacity Expansion: ₹60 Cr Investment
Borosil Scientific's board approved ₹60 Crore to build a new glassware plant in Bharuch. Capacity will expand from ~15 to ~108 lakhs units annually by March 2027.
- Value
- ₹60.00 Cr
- glassware production capacity addition
- 93 lakhs units per annum
Borosil Scientific Investor Presentation: Key Takeaways
Borosil Scientific reported Q1FY27 consolidated net sales of Rs. 106.8 Cr (11.2% YoY growth). Strategy focuses on diversifying from lab glassware into high-margin process equipment and pharma packaging.
- Call
- Guides 14% growth
Borosil Scientific Q1 FY27 Results: Turns Profitable, Net Profit ₹4.4 Cr
Borosil Scientific Ltd reported revenue from operations of ₹106.8 Cr (+11.2% YoY) and net profit of ₹4.4 Cr for Q1 FY27.
- Key figure
- Net profit ₹4.4 Cr
Borosil Scientific Q4 FY26 Results: Net Profit ₹27.2 Cr, Up 216.3% YoY
Borosil Scientific Ltd reported revenue from operations of ₹143.2 Cr (+10.6% YoY) and net profit of ₹27.2 Cr (+216.3% YoY) for Q4 FY26.
- Key figure
- Net profit ₹27.2 Cr · +216.3% YoY